What “Validated AI” Means in Pharma: Audit Trails and 21 CFR Part 11

In pharma, “validated” is a regulatory term. It describes a documented process, accepted by a regulatory authority, that demonstrates a system does what it’s supposed to do in its intended environment. Vendors often use it interchangeably with tested, reviewed, or reliable, but in a GxP context it’s a narrower, more specific claim than any of those words carry on their own. When someone in a GxP context says a system is validated, they mean it’s been through a formal qualification process, the documentation exists, a defined business process governs how the system is used, and a regulatory body has accepted it as fit for its intended use. Validation starts with that business process: who uses the tool, how the work flows, who approves user access, and who owns maintenance. That distinction is worth holding onto tightly, because vendors use “validated” loosely. The word shows up in sales decks as a vibe. In pharma, it has a specific meaning, and conflating the two creates real compliance risk.

What validation actually requires

Software validation in a GxP context follows a three-stage qualification process:

IQ (Installation Qualification): Is the system installed correctly? This stage confirms the software is deployed according to the vendor’s specifications, that dependencies are in place, and that the environment meets the defined requirements. It’s the baseline check before any functional testing begins.

OQ (Operational Qualification): Does the system do what it’s designed to do? This stage tests the system’s functions against its specifications under controlled conditions. You’re not yet testing it in your specific use context, you’re confirming it behaves the way it’s documented to behave.

PQ (Performance Qualification): Does the system perform correctly in the actual environment it’s used in, for the actual tasks it’s used for? This is the stage that ties the system to your specific workflows, your data, your users, and your intended purpose. It’s the most demanding stage, and the one most relevant to whether an AI workflow can be accepted as part of a regulated process.

All three stages require documentation, and the documentation isn’t a formality. It’s the substance. An inspector doesn’t look at the software and decide whether it works. They look at the documentation and decide whether the qualification process was rigorous enough to trust the system’s output in a regulatory context.

“Tested” and “validated” are not the same thing

Say your team ran fifty test cases against an AI workflow, everything passed, and the whole team felt good about shipping it. That’s testing. It’s a step inside the validation process, necessary but not sufficient on its own.

A system can be extensively tested and still not be validated. The difference is documentation, process, and regulatory acceptance. Validation requires a defined protocol written before the testing begins, a set of predetermined acceptance criteria, execution records showing what was done and by whom, and a summary report a qualified person has reviewed and approved. If you tested your AI workflow informally, ran some outputs past your team, decided they looked good, and called it ready, that’s development, not validation. Useful, but not the same thing, and it’s worth being honest with yourself about which one you actually did. This matters most when the AI workflow touches regulated data or contributes to a regulatory submission. At that point, “we tested it and it worked well” isn’t an answer an inspector can do anything with.

21 CFR Part 11 and AI workflows

21 CFR Part 11 is the FDA regulation that governs electronic records and electronic signatures in clinical data. If your AI workflow generates, modifies, maintains, or archives records that would otherwise exist on paper in a regulated context, Part 11 applies to it.

• Audit trails: The system must generate a computer-generated, time-stamped audit trail that records when records were created or modified, retained for at least as long as the records themselves.
• System access controls: Only authorized users can access the system, and access is limited to what each role actually requires.
• Electronic signatures: If electronic signatures are used, they must be uniquely associated with a specific individual and must include the signer’s printed name, the date and time of signing, and the meaning of the signature.
• Record integrity: Records must be protected from unauthorized alteration or deletion.

An AI workflow that drafts a clinical data finding, gets a human approval, and then stores that result as part of a regulatory submission is generating an electronic record. That record needs to meet Part 11 requirements, and the AI’s output along with the reviewer’s decision, identity, and timestamp are all part of it.

Validating output you can’t fully predict

Traditional validation assumes the same input always gives the same output. AI doesn’t. It can be fluent and wrong without any warning sign, give different answers on different runs, and change behaviour when the provider updates the model.

The risk itself isn’t anything new to the world of software and pharma. Software validation has always had to deal with logic that might be wrong. It never proved code correct. It managed the risk: it scaled testing to the impact of a failure, set acceptance criteria up front, and put every change under change control. AI needs the same approach but adapted for this new frontier:

Measure it, don’t just pass or fail it: Test against a reference dataset, with accuracy thresholds set before testing begins, and then ensure consistency.

Wrap it in checks that always give the same answer: Schema, range, and source-data checks catch errors mechanically.

Design the human review: Define what the reviewer checks, and record their decision with their name, timestamp and detailed metadata.

Lock the model version: An upgrade is always a change, and it gets re-tested to ensure nothing breaks.

Monitor in production: Sample live output and track how often reviewers override the AI for both a record and also as a measure of validation.

You don’t have to prove the AI is never wrong. You have to show you know how it can be wrong, and that you’d catch it if it goes astray before the losses or errors stockpile.

What makes an AI workflow ready for qualification

Three properties make an AI workflow a real candidate for the qualification process:

Versioned and locked: Whatever workflow definition ran a given process has to be on record, and if it changes, that’s a new version, qualified separately from the last one. For any output, on any date, you should be able to say exactly which workflow produced it, which model version, and what configuration it was running.

Traceable: Every input, output, model version, reviewer, and approval gets captured in a log, and not the kind someone maintains in a spreadsheet on the side. It happens in the system, automatically, as part of just running the thing.

Tamper-evident: A record that can be altered without anyone knowing is really just a suggestion. Any modification to a log entry needs its own trace: what changed, when, and who did it. An inspector has to be able to trust that what they’re looking at hasn’t been quietly edited after the fact.

A workflow built for qualification has these three baked in from day one, not added later: locked versions, complete execution traces, approval records the system writes itself at the moment of decision. Retrofitting them onto a system that wasn’t built this way is possible. It’s just a lot more work than building it in from the start.

What an inspector actually asks

When a decision made by an AI workflow gets questioned, an inspector isn’t asking whether the tool is good. They’re asking for the record. Specifically: which workflow version ran that day, what came into it, what the AI produced, and who looked at it and decided what, and exactly when. If answering that requires anyone to reconstruct anything from memory or from documentation assembled after the fact, you have a problem. That record has to already exist, in retrievable form, before anyone asks the question. The record is the answer. What an inspector wants is the actual log of what happened. A system walkthrough or a live demo won’t substitute for it. That’s why the audit trail is the core artifact that makes an AI workflow usable in a regulated context, not an afterthought bolted on at the end. Everything else, model quality, the interface, the speed, sits on top of that foundation. Without a trustworthy, complete, tamper-evident record, none of the other qualities matter much to an inspector.

Where to start if you are building toward qualification

If you’re not yet in a qualification process but know you’ll need to get there, start by asking three questions about your current AI tools:

1. Can you retrieve the exact workflow definition and model version that produced any specific output?
2. Is every human decision point captured automatically, with the reviewer’s identity and a timestamp?
3. Is the log tamper-evident, and can you demonstrate that to an auditor?

If the answers are no, or “we’d have to build that,” those are the gaps to address before the qualification process begins. It’s much easier to design for auditability from the start than to retrofit it into a system that wasn’t built with it in mind.